Clinical Trial Update: RE104 Safety and Efficacy Study in Postpartum Depression [Phase 2]

View source ↗

Summary

Phase 2 trial RE104 for postpartum depression has completed (status: COMPLETED); this update provides no efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• RE104

Snippet

Sponsor: Reunion Neuroscience Inc | Conditions: Postpartum Depression | Phase 2 | Status: COMPLETED